Breaking News
Investing Pro 0
🚨 Our Pro Data Reveals the True Winner of Earnings Season Access Data
Close

Medigene NA O.N. (MDG1k)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2.100 0.000    0.00%
03:40:31 - Closed. Currency in EUR ( Disclaimer )
  • Volume: 67,092
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 2.060 - 2.140
Type:  Equity
Market:  Germany
ISIN:  DE000A1X3W00 
WKN:  A1X3W0
Medigene 2.100 0.000 0.00%

MDG1k Balance Sheet

 
Featured here, the Balance Sheet for Medigene NA O.N., which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2022
30/06
2022
31/03
2021
31/12
2021
30/09
Total Current Assets 41.74 - 24.16 24.16
Cash and Short Term Investments 39.38 - 22.42 22.42
Cash - - - -
Cash & Equivalents 28.38 - 22.42 22.42
Short Term Investments 11 - - -
Total Receivables, Net 1.08 - 1.33 1.33
Accounts Receivables - Trade, Net 1.08 - 1.04 1.04
Total Inventory - - - -
Prepaid Expenses - - 0.395 0.395
Other Current Assets, Total 1.28 - 0.02 0.02
Total Assets 76.5 - 59.47 59.47
Property/Plant/Equipment, Total - Net 4.37 - 4.9 4.9
Property/Plant/Equipment, Total - Gross - - 17.91 17.91
Accumulated Depreciation, Total - - -13 -13
Goodwill, Net - - - -
Intangibles, Net 30.1 - 30.12 30.12
Long Term Investments - - - -
Note Receivable - Long Term - - 0.293 0.293
Other Long Term Assets, Total 0.287 - 0.287 0.287
Other Assets, Total 11.21 - -1.31 -1.31
Total Current Liabilities 6.91 - 8.03 8.03
Accounts Payable 0.688 - 0.498 0.498
Payable/Accrued - - - -
Accrued Expenses - - 1.81 1.81
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases 0.88 - 0.888 0.888
Other Current liabilities, Total 5.34 - 4.84 4.84
Total Liabilities 17.36 - 14.65 14.65
Total Long Term Debt 2.85 - 3.14 3.14
Long Term Debt - - - -
Capital Lease Obligations 2.85 - 3.14 3.14
Deferred Income Tax 2.28 - 2.52 2.52
Minority Interest - - - -
Other Liabilities, Total 5.31 - 0.97 0.97
Total Equity 59.14 - 44.82 44.82
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 24.56 - 24.56 24.56
Additional Paid-In Capital - - 479.59 -
Retained Earnings (Accumulated Deficit) -447.76 - -461.68 -461.68
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - 2.25 -
Other Equity, Total 482.34 - 481.94 481.94
Total Liabilities & Shareholders' Equity 76.5 - 59.47 59.47
Total Common Shares Outstanding 24.56 24.56 24.56 24.56
Total Preferred Shares Outstanding - - - -
* In Millions of EUR (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MDG1k Comments

Write your thoughts about Medigene NA O.N.
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email